FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

39488311000001100: Ravulizumab 300mg/3ml solution for infusion vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Apr 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
619001000001115 Ravulizumab 300mg/3ml solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
619021000001110 Ravulizumab 300mg/3ml solution for infusion vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ravulizumab 300mg/3ml solution for infusion vials Is a Ravulizumab true Inferred relationship Existential restriction modifier
Ravulizumab 300mg/3ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninfusion.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Ravulizumab 300mg/3ml solution for infusion vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ravulizumab 300mg/3ml solution for infusion vials Is a Ravulizumab false Inferred relationship Existential restriction modifier
Ravulizumab 300mg/3ml solution for infusion vials Has specific active ingredient Ravulizumab true Inferred relationship Existential restriction modifier
Ravulizumab 300mg/3ml solution for infusion vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Ravulizumab 300mg/3ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Ravulizumab 300mg/3ml solution for infusion vials Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Ravulizumab 300mg/3ml solution for infusion vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ravulizumab 300mg/3ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Ravulizumab 300mg/3ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ravulizumab 300mg/3ml solution for infusion vials 1 vial Has VMP True Ravulizumab 300mg/3ml solution for infusion vials Inferred relationship Existential restriction modifier
Ultomiris 300mg/3ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) Is a True Ravulizumab 300mg/3ml solution for infusion vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start